Regulatory Impact Assessment
You’re expanding into a new market. You need to know what the regulatory environment actually means for your product — not a list of laws, but a clear picture of what applies, what’s changing, and what it means for how you enter, partner, and deploy.
What it is
A Regulatory Impact Assessment (RIA) from HealthTechAsia is a structured analysis of how existing and emerging regulations may shape the operational, economic, and strategic dimensions of your innovation. It helps organisations anticipate regulatory implications, assess risks and opportunities, and make informed decisions around deployment, partnerships, and market entry.
We go beyond the statute. We interpret the regulatory environment in context, drawing on our editorial relationships with regulators, policymakers, and health system leaders across ASEAN and the Middle East to give you a picture that reflects how policy actually operates on the ground.
What you get
- A written assessment of the regulatory landscape as it applies to your product category and market entry model
- Analysis of upcoming policy changes and their likely operational implications
- Identification of key approval pathways, data residency requirements, and partnership constraints
- Practical recommendations on sequencing, risk areas, and where to engage early
- Delivered as a professionally formatted PDF brief, typically 8-15 pages
- Benchmarking of regulatory readiness against emerging international trends and best practices, where relevant
Who this is for
Health AI companies, digital health platforms, and MedTech firms preparing to enter or expand in ASEAN or the Gulf — particularly those navigating SaMD classifications, health data regulations, or AI-specific governance requirements for the first time.
To get started
Send a brief note to team@healthtechasia.co with the market you’re entering and a short description of your product or service. We’ll confirm scope and availability within two business days.